Orchid To Develop Merck’s Anti-Coagulant; To Buy Majority Stake In Diakron

MUMBAI - Chennai-based injectible cephalosporin manufacturer Orchid Chemicals will develop and manufacture an oral anti-coagulant drug that was initially discovered by U.S. drug maker Merck

More from Archive

More from Scrip